Abstract:The efficacy of the anticancer drug doxorubicin (Dox) is limited by an insufficient cellular uptake and drug resistance, which is partially due to ion trapping in acidic environments such as the extracellular environment of solid tumors and the interior of endolysosome vesicles. Herein, we describe the preparation and in vitro evaluation of a new type of nanohybrid for anticancer drug delivery which is capable of carrying a high load of the cationic Dox through the cell membrane. In addition, the nanohybrids use the acidic environment of the endolysosomes to release the drug, simultaneously helping to disrupt the endolysosomes and diminishing endolysosome Dox trapping. Furthermore, as the nanohybrid carriers are capable of sustained drug delivery, those that remain in the cytoplasm and still contain Dox are expected to exert a prolonged anticancer activity. Briefly, Dox is loaded onto biocompatible anionic Laponite(®) (LP) nanodisks with a high aspect ratio (25 nm in diameter and 0.92 nm in thickness) through strong electrostatic interactions to get Dox-loaded LP disks. Alginate (AG), a biocompatible natural polymer, is then coated onto the Dox-loaded LP disks (LP/Dox/AG nanohybrids) to prevent the burst release of the drug. The results demonstrate that the nanohybrids have a high encapsulation efficiency (80.8 ± 10.6%), are sensitive to pH and display a sustained drug release behavior. Cell culture experiments indicate that the LP/Dox/AG nanohybrids can be effectively internalized by CAL-72 cells (an osteosarcoma cell line), and exhibit a remarkable higher cytotoxicity to cancer cells than the free Dox. The merits of Laponite(®)/alginate nanohybrids, such as biocompatibility, high loading capacity and stimulus responsive release of cationic chemotherapeutic drugs, render them as excellent platforms for drug delivery.

Fabrication of Alginate/Calcium Carbonate Hybrid Microparticles for Synergistic Drug Delivery.

Multi-drug delivery system based on alginate/calcium carbonate hybrid nanoparticles for combination chemotherapy.

Polymer-lipid Hybrid Nanoparticles Synchronize Pharmacokinetics of Co-Encapsulated Doxorubicin-Mitomycin C and Enable Their Spatiotemporal Co-Delivery and Local Bioavailability in Breast Tumor.

Calcium Carbonate/Carboxymethyl Chitosan Hybrid Microspheres and Nanospheres for Drug Delivery

Ionic Microgel Loaded with Gold Nanoparticles for the Synergistic Dual-Drug Delivery of Doxorubicin and Diclofenac Sodium

Development of a Dual Drug-Loaded Hydrogel Delivery System for Enhanced Cancer Therapy: in Situ Formation, Degradation and Synergistic Antitumor Efficiency

Ph-Sensitive Laponite®/doxorubicin/alginate Nanohybrids with Improved Anticancer Efficacy

Biodegradable Photothermal and Ph Responsive Calcium Carbonate@Phospholipid@Acetalated Dextran Hybrid Platform for Advancing Biomedical Applications

Drug-mediation Formation of Nanohybrids for Sequential Therapeutic Delivery in Cancer Cells.

Immobilization of Coacervate Microcapsules in Multilayer Sodium Alginate Beads for Efficient Oral Anticancer Drug Delivery

In Situ DOX-calcium Phosphate Mineralized CPT-amphiphilic Gelatin Nanoparticle for Intracellular Controlled Sequential Release of Multiple Drugs.

Synergistic Occlusion of Doxorubicin and Hydrogels in CaCO3 Composites for Controlled Drug Release

Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency.

Multi‐functional heparin–biotin/heparin/calcium carbonate/calcium phosphate nanoparticles for targeted co‐delivery of gene and drug

Composite Core-Shell Microparticles from Microfluidics for Synergistic Drug Delivery

Dual stimuli-responsive polypeptide-calcium phosphate hybrid nanoparticles for co-delivery of multiple drugs in cancer therapy.

Alginate/Caco3 Hybrid Nanoparticles For Efficient Codelivery Of Antitumor Gene And Drug

Alginate–calcium carbonate porous microparticle hybrid hydrogels with versatile drug loading capabilities and variable mechanical strengths

Dual-pH Responsive Micelle Platform for Co-Delivery of Axitinib and Doxorubicin

Fabrication of Graphene Oxide-Β-cyclodextrin Nanoparticle Releasing Doxorubicin and Topotecan for Combination Chemotherapy

Synchronized Delivery of Dual-Drugs for Potentiating Combination Chemotherapy Based on Smart Triple-Responsive Polymeric Micelles